Jenab Y, Sadeghipour P, Mohseni-Badalabadi R, Kaviani R, Hosseini K, Pasebani Y
EuroIntervention. 2025; 21(1):82-92.
PMID: 39773831
PMC: 11684328.
DOI: 10.4244/EIJ-D-24-00527.
Heyne S, Macherey-Meyer S, Meertens M, Finke K, Baldus S, Adler C
Clin Res Cardiol. 2024; .
PMID: 39297938
DOI: 10.1007/s00392-024-02547-7.
Chen Q, Wang L, Katsouras C, Gong M, Liu C, Lian L
Nat Commun. 2024; 15(1):6883.
PMID: 39128927
PMC: 11317478.
DOI: 10.1038/s41467-024-51121-2.
Li J, Hu Y, Wu Z
Rev Cardiovasc Med. 2024; 23(9):312.
PMID: 39077723
PMC: 11262343.
DOI: 10.31083/j.rcm2309312.
Kaddoura R, Orabi B, Yassin M, Omar A
Rev Cardiovasc Med. 2024; 24(6):180.
PMID: 39077529
PMC: 11264133.
DOI: 10.31083/j.rcm2406180.
Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus.
Yang Q, Liang Y, Quan X, Lang X, Gao D
Rev Cardiovasc Med. 2024; 24(3):74.
PMID: 39077494
PMC: 11263983.
DOI: 10.31083/j.rcm2403074.
Impacts of Diabetes Mellitus on Cardiovascular Outcomes and Differential Effects of Direct Oral Anticoagulants in Patients with Left Ventricular Thrombus.
Shi B, Zhang R, Song C, Cui K, Zhang D, Jia L
Rev Cardiovasc Med. 2024; 24(3):65.
PMID: 39077488
PMC: 11264001.
DOI: 10.31083/j.rcm2403065.
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial.
Mansouri P, Jazi Z, Mansouri M, Dehghan H, Zavar R, Hashemi S
Thromb J. 2024; 22(1):66.
PMID: 39030573
PMC: 11264466.
DOI: 10.1186/s12959-024-00632-5.
Meta-Analysis of the Safety and Efficacy of Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus.
Vorla M, Kalra D
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931375
PMC: 11206604.
DOI: 10.3390/ph17060708.
Factors predicting resolution of left ventricular thrombus in different time windows after myocardial infarction.
Lu Z, Song B, Liu X, Zhang N, Li F, Xu F
BMC Cardiovasc Disord. 2024; 24(1):278.
PMID: 38811882
PMC: 11134760.
DOI: 10.1186/s12872-024-03898-9.
Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant Approaches.
Colle B, Demeure F, Higny J, Benoit M, Henry J, Michaux I
Diagnostics (Basel). 2024; 14(9).
PMID: 38732361
PMC: 11083388.
DOI: 10.3390/diagnostics14090948.
Left ventricular reverse remodelling as a promising strategy for resolving left ventricular thrombus.
Chen X, Zhang X, Yang Y, Sun Y, Si J, Jiang S
ESC Heart Fail. 2024; 11(4):2214-2222.
PMID: 38628024
PMC: 11287347.
DOI: 10.1002/ehf2.14781.
Are direct oral anticoagulants preferable to warfarin for the treatment of left ventricular thrombi? A Bayesian meta-analysis of randomized controlled trials.
Sayed A, Ghonim M, Ghonim M, Awad A, Saleh Y, Abdelfattah O
Am Heart J Plus. 2024; 12:100066.
PMID: 38559599
PMC: 10978137.
DOI: 10.1016/j.ahjo.2021.100066.
Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus- a meta-analysis update.
Hu T, Chen C, Maduray K, Han W, Chen T, Zhong J
Thromb J. 2024; 22(1):23.
PMID: 38429631
PMC: 10905864.
DOI: 10.1186/s12959-024-00585-9.
Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta-analysis.
Shrestha D, Dawadi S, Dhakal B, Shtembari J, Patel T, Shaikh R
Health Sci Rep. 2023; 6(11):e1736.
PMID: 38028683
PMC: 10667961.
DOI: 10.1002/hsr2.1736.
Systemic right ventricle complications in levo-transposition of the great arteries: A case report and review of literature.
Almajed M, Almajed A, Khan N, Obri M, Ananthasubramaniam K
World J Cardiol. 2023; 15(10):542-552.
PMID: 37900900
PMC: 10600789.
DOI: 10.4330/wjc.v15.i10.542.
Safety of dobutamine or adenosine stress cardiac magnetic resonance imaging in patients with left ventricular thrombus.
Weberling L, Seitz S, Salatzki J, Ochs A, Heins J, Haney A
Clin Res Cardiol. 2023; 113(3):446-455.
PMID: 37843560
PMC: 10881726.
DOI: 10.1007/s00392-023-02317-x.
Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus.
Kitano T, Nabeshima Y, Kataoka M, Takeuchi M
Sci Rep. 2023; 13(1):13203.
PMID: 37580355
PMC: 10425444.
DOI: 10.1038/s41598-023-40389-x.
Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation.
Zhang Q, Zhang Z, Zheng H, Wang C, Yu M, Si D
Thromb J. 2023; 21(1):75.
PMID: 37430265
PMC: 10332057.
DOI: 10.1186/s12959-023-00520-4.
Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy.
Patail H, Sharma T, Bali A, Isath A, Aronow W, Haidry S
Arch Med Sci Atheroscler Dis. 2023; 8:e13-e18.
PMID: 37153377
PMC: 10161787.
DOI: 10.5114/amsad/161172.
